Acute Heart Failure and Coronary Blood Flow in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study.

coronary flow killip neurohumoral no-reflow perfusion stemi thrombus

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Dec 2023
Historique:
accepted: 11 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

Background and objective The Global Registry of Acute Coronary Events (GRACE) study showed poor outcomes in ST-elevation myocardial infarction (STEMI) patients with acute heart failure (AHF) at hospital admission in terms of increased in-hospital and six-month mortality and readmission rates. In this study, we aimed to examine the effects of AHF at the time of admission on the coronary thrombus burden and post-primary percutaneous coronary intervention (PPCI) coronary flow among STEMI patients. Methods We conducted a cohort study involving 210 consecutive STEMI patients who presented to a single PPCI centre between June 2016 and January 2017. We classified them into two groups based on their Killip class at the time of presentation to the emergency department: no heart failure (NHF) and AHF groups. The primary outcome was the incidence of Thrombolysis In Myocardial Infarction (TIMI) flow grade of less than 3 in the stented coronary artery in the absence of mechanical obstruction or dissection (also known as no-reflow). The secondary outcome was the presence of a heavy thrombus burden (TIMI grade 4 or 5) at the time of angiography. Results The AHF group had a significantly higher incidence of no-reflow than the NHF group (25% vs. 8.4%, p=0.019). However, the prevalence of heavy thrombus burden did not differ significantly between the two groups (50% in the AHF group vs. 43.16% in the NHF group, p=0.557). The multivariable logistic regression analysis showed that AHF was an independent predictor of no-reflow in STEMI patients post-PPCI [Odds ratio (OR): 3.59, 95% confidence interval (CI): 1.09-11.83, p=0.035]. Conclusion Based on our findings, AHF is associated with an increased risk of no-reflow in STEMI patients post-PPCI, irrespective of the coronary thrombus load.

Identifiants

pubmed: 38205479
doi: 10.7759/cureus.50340
pmc: PMC10781414
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e50340

Informations de copyright

Copyright © 2023, Elkammash et al.

Déclaration de conflit d'intérêts

The first and corresponding author (Dr Amr Elkammash) worked as a Cardiology specialist in the International Cardiac Center, Alexandria, Egypt, at the time when the study was carried out, and his current affiliation represents his most recent place of work. The study’s abstract was presented at the Acute Cardiovascular Care Conference held in Marseille, France in 2023, and was published in the ESC Acute Cardiovascular Care journal supplement in May 2023. However, the detailed manuscript has never been published before.

Auteurs

Amr Elkammash (A)

Cardiology, Bristol Heart Institute, Bristol, GBR.

Mohamed Abdelhamid (M)

Cardiology, Alexandria University, Alexandria, EGY.

Mohamed Sobhy (M)

Cardiology, Alexandria University, Alexandria, EGY.

Amr Zaki (A)

Cardiology, Alexandria University, Alexandria, EGY.

Mohamed Sadaka (M)

Cardiology, Alexandria University, Alexandria, EGY.

Oluwamayowa N Omoniyi (ON)

Cardiology, Peterborough City Hospital, Peterborough, GBR.

Mustafa Alsinan (M)

Internal Medicine, Princess of Wales Hospital, Bridgend, GBR.

Rasha M Farahat (RM)

Family Medicine, West Suffolk NHS Foundation Trust, Suffolk, GBR.

Aya Al Sattouf (A)

Medicine, King's College Hospital, London, GBR.

Khaled Madi (K)

Internal Medicine, University Hospitals Dorset NHS Foundation Trust, Bournemouth, GBR.

Classifications MeSH